Middle Molecules in Renal Failure

Abiko T. Kumikawa M. Hiroki H. Sekino H. (1978). Identification and synthesis of a heptapeptide in uremic fluid. Biochemical and Biophysical Research Communications, 84, 184.

Babb A. L. Farrell P. C. Uvelli D. A. Scribner B. H. (1972). Hemodialyzer evaluation by examination of solute molecular spectra. Transactions of the American Society for Artificial Internal Organs (Washington), 18, 98.

Babb A. L. Johansen P. J. Strand M. J. Tenckhoff H. Scribner B. H. (1973). Bidirectional permeability of the human peritoneum to middle molecules. Proceedings of the European Dialysis and Transplant Association, 10, 247.

Babb A. L. Popovich R. P. Christopher T. C. Scribner B. H. (1971). The genesis of the squaremeterhour hypothesis. Transactions of the American Society for Artificial Internal Organs (Washington), 17, 81.

Bergström J. Asaba H. Fürst P. Gordon A. Quadracci L. Zimmerman L. (1976). Middle molecules in uremia. Proceedings of the 6th International Congress of Nephrology, edited by Giovanetti S. Bonomini V. D'Amico G. , p. 600. Karger, Basel.

Bergströmm J. Fürst P. (1976). Uremic middle molecules. Clinical Nephrology, 5, 143.

Bergström J. Fürst P. (1978). Uraemic toxins. In Replacement of Renal Function by Dialysis, edited by Drukker W. Parsons F. H. Maher J. F. , p.334. M. Nijhoff, (Medical Division) The Hague.

Christopher T. G. Cambi V. Harker L. A. Hurst P. E. Popovich R. P. Babb A. L. Scribner B. H. (1971). A study of hemodialysis with lowered dialysate flow rate. Transactions of the American Society for Artificial Internal Organs (Washington), 17, 92.

Cristol P. Jeanbrau E. Monnier P. (1938). La polypeptidémie en pathologie rénale. Journal Médical Français, 27, 24.

Cueille G. Man N. K. Sausse A. Funck-Brentano J. L. (1978). Purification and identification of a middle molecular weight neurotoxin in uremic patients. (Abstract). 7th International Congress of Nephrology, pp. 1–16.

Dall'Aglio P. Buzio C. Cambi V. Arisi L. Migone L. (1972). La rétention de moyennes molecules dans le serum urémique. Proceedings of the European Dialysis and Transplant Association 9, 409.

Dési I. Férer I. Weisz P. Szold E. (1957). Untersuchung der Toxizität des mit Ionenaustauschharzen behandelten urämischen Blutes. Zeitschrift fur die Gesamte Innere Medizin und Ihre Granzgabiete, 12, 1127.

Dzurik P. Adam J. Valovicova E. Reznicek J. Zvara V. (1971). The effect of haemodialysis in blood peptide levels. Proceedings of the European Dialysis and Transplant Association, 8, 167.

Finelli V. N. Klauder D. S. Karaffa M. A. Peterning H. G. (1975). Interaction of zinc and lead on D-Aminolevulinate dehydratase. Biochemical and Biophysical Research Communications, 65, 303.

Funck-Brentano J. L. Man M. K. Sausse A. Zinggraff J. Boudet J. Becker A. Cuielle G. F. (1976). Characterization of a 1100–1300 MW neurotoxin Transactions of the American Society for Artificial Internal Organs (Washington), 22, 163.

Fürst P. Zimmermann L. Bergström J. (1976). Determination of endogenous middle molecules in normal and uremic body fluids. Clinical Nephrology, 5, 178.

Ginn H. E. Bugel H. J. James L. Hopkins P. (1971). Clinical experience with small surface area dialysers (SSAD). Proceedings of the Clinical Dialysis and Transplant Forum (Washington), 1, 53.

Goubeaud G. Leber H. W. Schott H. H. Schütterle G. (1976). Midlde molecules and hemoglobin-synthesis. Proceedings of the European Dialysis and Transplant Association, 13, 113.

Goubeaud G. Schott H. H. (1977). Auftrennung von Mittelmolekülen aus Urämikerserum, Normalurin und Hämodialysat mit Hilfe von Ultrafiltration, Molekularsieb- und Adsorptionschromatographie. Klinische Wochenschrift, (In press).

Jebsen R. H. Tenckhoff H. Hoult J. C. (1967). Natural history of uremic polyneuropathy and the effects of dialysis. New England Journal of Medicine 277, 327.

Leber H. W. Baumgarten C. Goubeaud G. Matthias R. Schütterle G. (1975). Globin synthesis in uremia. Proceedings of the European Dialysis and Transplant Association, 12, 325.

Leber H. W. Goubeaud G. Pohlreich J. Schütterle G. (1978). Untersuchungen zur Pathogenese des Leberkomas: Nachweis “mittelgrosser” Peptide. Verhandlungen der Deutschen Gesellschaft fur Innere Medizin. 8, 1076.

Leber H. W. Goubeaud G. Spiegelhalter R. Rawer P. (1979). Untersuchungen zur Bedeutung mittelgrosser Moleküleals Urämietoxine. Medizinische-Welt, 30, 161.

Leber H. W. Sinning P. Schütterle G. (1974). New aspects concerning uremic anemia: prophobilinogen and porphyrin synthesis in reticulocytes from uremic patients. Proceedings of the European Dialysis and Transplant Association, 11, 383.

Leber H. W. Spiegelhalter R. Schütterle G. (1978). A new aspect concerning uraemic haemolysis: increased susceptibility of erythrocytes to peroxidation. Proceedings of the European Dialysis and Transplant Association, 15, 437.

Leber H. W. Spiegelhalter R. Ulm A. Goubeaud G. Rawer P. (1979). Influence of middle molecules on the anemia of uremic patients. Artificial Organs, 2, 378.

Piorry et L'Heritier (1840). Traite' des Alterations du Sang. Paris.

Scribner B. H. (1965). Discussion. Transactions of the American Society for Artificial Internal Organs (Washington), 11, 29.

Tenckhoff H. Curtis F. H. (1970). Experience with peritoneal dialysis in the home. Transactions of the American Society for Artificial Internal Organs (Washington), 16, 90.

Zimmermann L. Baldesten A. Bergström J. Fürst P. (1979). Isotachophoretic separation of middle molecule peptides in uremic body fluids. Preliminary Proceedings of the 1st International Symposium on the Biochemical and Biological Application of Isotachophoresis, Baconfoy.